The potential use of lasers to vaporise atherosclerotic plaque obstructions is rapidly becoming recognised. The . ' 
with properties similar to light from an ordinary light bulb. However, laser light differs from ordinary white light in that it is monochromatic: the laser generates photons with a narrow band of wavelengths. It is also coherent: the photons are in phase with each other and coordinated in time and space. Furthermore, it is collimated, and the light waves are parallel to one another and move in one direction. Thus this highly collimated and coherent light can be packaged and focused into a very tiny but powerful beam, capable of vaporising atherosclerotic plaque obstruction.
The typical laser consists of a resonant cavity which contains the active lasing medium. The latter is bounded by parallel mirrors at both ends; one end fully reflective and the other end only partially reflective, allowing the escape of laser light for medical application ( Figure I ). The atoms in the active medium can be primed electronically to an excited energy state. When an atom returns to a lower energy state, a photon is spontaneously emitted. When this photon interacts with another atom that is in a high energy state, this OOSb 
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95<*> REFLECTIVE MIRROR ELECTRIC CURRENT Figure 1 The lasing medium is bounded by a 100% reflective mirror at one end and a 95% reflective mirror at the other end. Primed by an electric current to high energy states, the atoms in the lasing medium, upon return to a lower energy state, emit photons which result in emission of highly coherent light.
results in the production of two photons having the same frequency and travelling in the same direction. These two photons can stimulate other high-energy atoms, thereby emitting four photons, and so on. Thus the term 'laser' was developed from the acronym fight amplification by stimulated emission of radiation.
There are a variety of different types of lasers; each generates a narrow band of wavelengths specific to the • lasing medium. The most common lasers used fo.r L medical applications are the argon, carbon dioxide (CO 2 ) and neodymium and yttrium-aluminium-, garnet (Nd: YAG). The first two are gas lasers and the last is a solid-state laser. The argon laser produces wavelengths of 0-488 and 0-514 \im in the green part of the visible spectrum. The Nd: YAG and CO 2 lasers r have wavelengths of 106 pan (near infra-red) andV 10.6 nm (middle infra-red), respectively. The argon or Nd: YAG laser energies can be transmitted by flexible " optical fibre made of silica ( Figure 2 ). The use of these ,' lasers upon the atherosclerotic plaque is based on the transformation of light energy into heat, which causes , the destruction or removal of plaque by coagulation, carbonisation, and volatilisation.
The coronary atherosclerotic plaque
Since the laser destruction of plaque is in part related to the thermal and optical properties of the plaque, it is important to understand the physical and biochemical composition of the atherosclerotic obstruction. Characteristically, the atherosclerotic plaque is a * raised, pearly grey to yellowish grey lesion causing the . Biochemical analysis indicates that the plaque is composed of -/heterogeneous mixtures of cholesterol, cholesterol esters, lipoproteins, proteoglycans, phospholipids,. glycerol esters, and calcium salts. While the plaque can totally occlude a coronary artery by itself, more often it predisposes the artery to . obstruction by the formation of a vascular thrombus.
Acute myocardial infarction is highly associated with a sudden occlusion of a coronary artery by a fresh thrombus 1 " 1 , which is a complex aggregation of blood platelets, white cells and red cells in the fibrin network. The absorption of laser energies by each of these different substances in the obstructed vessel may differ according to the wavelength emitted by the laser.
T Effects of lasers on coronary atherosclerotic plaque obstruction
Studies demonstrating the effects of laser radiation upon human coronary atherosclerotic obstructions from postmortem hearts have been reported 116 " 19 '. Laser energies from a variety of commonly used , medical lasers, including the argon, Nd:YAG and CO 2 , are capable of penetrating and vaporising athero--sclerotic plaques. The ease of penetration is largely dependent upon the absorptive characteristics of the plaque substances, beam focus, the power intensity and the duration of laser exposure. Due to the plaque's heterogeneity spectrophoto-* metric absorption studies to characterise the plaque are difficult to obtain. However, vaporisation is more rapid in plaques containing lipid than in plaques with heavily calcified deposits. Moreover, laser radiation of fibrous areas and especially of calcified areas caused remnants of charred debris in the irradiated pathway, whereas this was usually not the case when exposure was focused over a primarily fatty plaque 1 ' 61 . In general, the higher the power intensity, the longer the exposure time, and the more focused the laser beam, the greater is the plaque penetration 1 ' 7| . The total energy (joules) delivered to the plaque is the product of the power (watts) and the duration of exposure (seconds). If power is kept constant, the larger the surface area irradiated, the lower the concentration or power density. Thus, increasing beam diameter twofold will increase the surface area by four times and decrease power density to one-quarter. Conversely, reducing the beam diameter by one-half will decrease surface area to one-quarter and increase power density by a factor of four.
Laser radiation penetrated plaque better under dry than wet conditions. Under dry conditions CO 2 laser produced plaque damage with just 2-5 joules of total energy. However, it took more than 5 joules to reproduce identical plaque damage when the vessel was immersed in saline solution'
181
. Furthermore, the application of certain dyes and pigments (e.g., fluorescein, sudan black, haemoglobin) may increase laser absorption and enhance plaque damage 1201 . Should these or other substances prove to bind or stain plaque, a lower-power beam can be utilised, lessening (he risk of thermal injury to the adjacent normal vascular wall.
The arterial response to laser radiation was studied in animals fed a hyperlipidemic diet to induce atherosclerosis. Laser energies of less than 10 joules (exposure times of 0-1-0-5 s at 1-20 W) produced vaporised craters of approximately 1 mm in depth and 2 mm in diameter in surgically exposed atherosclerotic vessels. The animals were followed for 2 days to 8 weeks. Early after laser exposure, the crater was covered with platelet-fibrin thrombi. The surface of the crater had re-endothelialised with some fibrin and platelets remaining by 2 weeks, and was still visible as a reendothelialised crater by 8 weeks'
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. Moreover, no significant thrombogenic complication was observed.
Effects of laser on thrombotic obstruction
Since blood clots are comprised of red blood cells which contain haemoglobin pigments, they are readily absorbed by argon energies. The argon laser is capable of vaporising and penetrating thrombus in a linear dose-response fashion'
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. The longer the clot, the higher the power intensity or beam exposure time needed to canalise the organised thrombus.
The thrombus can be further separated into red (whole blood plus fibrinogen plus thrombin) and white clot (fibrinogen plus thrombin). Argon energies penetrated red but not white clots' 231 . Since spectrophotometric studies demonstrate that the former (containing haemoglobin) but not the latter absorb light from the argon wavelength band, the argon laser provides the therapeutic modality for lysis of human red clot, while a different laser source is required for white clot dissolution. Furthermore, water attenuates argon energies, hence a fresh (wet and soft) clot, in contrast to organised thrombus, may be better dissolved with a thrombolytic agent such as streptokinase, urokinase, or tissue plasminogen activator.
Potential adverse effects
To simulate clinical laser angioplasty, a flexible optical fibre used to transmit laser irradiation was inserted into a guiding catheter positioned by fluoroscopy in the coronary orifice in animals' 2 * 1 . Argon energies approaching those used to dissolve atherosclerotic plaque and thrombotic obstructions were applied. Coronary perforation was a frequent complication, producing pericardial tamponade and haemodynamic and electrical instability . Muscular wall damage with aneurysm formation developed in half of the animals followed for several days'
231 . These complications are common when catheter laser angioplasty is randomly applied without visualisation of the specific plaque target and/or using safe dose increments of power intensity and duration of exposure.
Furthermore, the transmission of argon energies into blood exposes human red blood cells to intense heat. Consequently, there was lysis of erythrocytes as reflected by a fall in haematocrit in cells subjected to direct laser exposure and thermal damage to the erythrocyte membrane of red blood cells in the surrounding medium, as shown by a rise in plasma haemoglobin'
261
. Prolonged laser firing using the flexible quartz fibre immersed in a blood-filled vessel caused blood clotting at the fibre tip as detected by two-. dimensional echocardiography 1271 .
The laser cautery cap and its effects on vascular obstructions
Since laser radiation delivered by available flexible quartz fibres for vaporising atherosclerotic plaque y obstructions presents risks to the operating personnel (i.e., retinal damage), as well as subjecting patients tocomplications such as vascular damage, aneurysm, and perforation, we have attempted to minimise these untoward problems of the beam straying and/or scattering from its target by mounting a metal cap at the distal fibre-optic tip'
281 . The original idea was based k upon our work in the late 1970s using an electrically heated metal cap device which was successful in dissolving atherosclerotic fatty fibrous plaques.
The metallic tip at its distal end was heated by laser energies from an argon-ion laser source and directed into the diseased human cadaver plaques'
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. The plaques were instantly vaporised on contact with the metal cap (Figure 3 ). The depth of penetration was < largely dependent on the contact time and the physical characteristics of the plaque obstruction. Following ' the laser-heated metal cap treatment, there was no entrapped debris in the treated regions'
. This differs from the situation following the shattering effect of vaporisation caused by direct laser free-beam radia- 13 ''. Another catheter assembly (3 mm outer diameter and 100 cm long) is connected to a "viewing handpiece, which could be attached to a television monitor. This device has three hollow passageways extending from the handpiece to the catheter tip. These are channels for viewing, laser delivery and suction/flushing. Early experimental work using this instrument , demonstrated its ability to visualise and vaporise atherosclerotic plaques implanted in living animals' 32 '. •• By viewing the obstruction, the operator can direct the laser beam to the diseased target for controlled thermal therapy, avoiding the normal vascular wall and thereby minimising the risks of perforation and aneurysm formation. Moreover, the visualisation of ••the obstruction can help distinguish plaque from thrombus, which is important, since different energies * may be required for laser absorption. The use of this new laser technology may someday revolutionise the treatment of atherosclerosis. Vascular surgeons have begun early intraoperativê work using lasers on diseased peripheral arteries. Gradual progress to smaller vessels, including the • coronary arteries, is planned. Although the potential for dissolving coronary obstruction by phototherapeutic techniques is great, a further understanding of laser vascular consequences and improvements in laser delivery systems are needed * before it is applied in man.
